Healthcare Services US

US India Diagnostic Chains Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

US India Diagnostic Chains Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $6.66 Bn Placeholder estimate
Estimate 2025 $7.23 Bn 45.2% of the global market
Projected 2034 $15.20 Bn 110.1% Adds $7.97 Bn over 9 forecast years
CAGR 2025–2034 8.6% Faster than 64% of 107 Healthcare Services markets here
Key players 5 Companies profiled
  • US is 45.17% of the global market.
  • In North America, the largest is US (this report) at $7.23 Bn.
  • Fastest growing: Canada at 10.6% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$7.97 Bn total, 2026–2034

Year-by-year market size, 2024–2034
India Diagnostic Chains Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $6.66 Bn — —
2025 (base) $7.23 Bn +$572.9 Mn —
2026 (forecast) $7.86 Bn +$622.2 Mn +8.6%
2027 (forecast) $8.53 Bn +$675.7 Mn +17.9%
2028 (forecast) $9.27 Bn +$733.8 Mn +28.1%
2029 (forecast) $10.06 Bn +$796.9 Mn +39.1%
2030 (forecast) $10.93 Bn +$865.4 Mn +51.1%
2031 (forecast) $11.87 Bn +$939.8 Mn +64.1%
2032 (forecast) $12.89 Bn +$1.02 Bn +78.2%
2033 (forecast) $14.00 Bn +$1.11 Bn +93.5%
2034 (forecast) $15.20 Bn +$1.20 Bn +110.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US India Diagnostic Chains Market Analysis at a glance
Market size, 2025$7.23 Bn placeholder estimate
Forecast, 2034$15.20 Bn placeholder estimate
Growth (CAGR), 2025–20348.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest and channel (see all)
Key playersDr Lal PathLabs, Metropolis Healthcare, Thyrocare Technologies, Agilus Diagnostics, Redcliffe Labs (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US India Diagnostic Chains Market Analysis Executive Summary

India diagnostic chains run networks of labs and collection centres offering blood tests, imaging and home sample collection.

Key segments of the india Diagnostic Chains market include test (Pathology, Radiology and Preventive Health Packages) and channel (Centres, Home Collection and Hospital Labs).

Bar chart: US India Diagnostic Chains market size, 2024–2034, placeholder estimates. $6.66 Bn in 2024, $7.23 Bn in 2025 and $15.20 Bn in 2034, 8.6% CAGR.
US India Diagnostic Chains market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US India Diagnostic Chains Market Dynamics

Market Growth Drivers

Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the india Diagnostic Chains market.

Opportunity

Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the india Diagnostic Chains market strong room to grow.

Market Restraints

Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the india Diagnostic Chains market.

Competitive Landscape for India Diagnostic Chains Market in US

The india Diagnostic Chains market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for India Diagnostic Chains Market in US

India Diagnostic Chains in the US: payment

Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[1]

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how india Diagnostic Chains services are delivered and paid for in US. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in India Diagnostic Chains right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

India Diagnostic Chains in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the India Diagnostic Chains market in the US?
Placeholder estimate: about $7.23 Bn in 2025, rising to about $15.20 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the India Diagnostic Chains market in the US growing?
Placeholder estimate: about 8.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the India Diagnostic Chains market report cover?
The report splits the market by test (Pathology, Radiology, Preventive Health Packages, Specialized Tests) and channel (Centres, Home Collection, Hospital Labs).
Who are the key players in the India Diagnostic Chains market?
Key players include Dr Lal PathLabs, Metropolis Healthcare, Thyrocare Technologies, Agilus Diagnostics and Redcliffe Labs.
What is driving the India Diagnostic Chains market?
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the india Diagnostic Chains market.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in US

See all

Related on diagnostics and lab testing

See the topic